IL6 and Renal insufficiency: These metabolites significantly inhibit the expression and release of inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6) induced by podocyte injury, which helps improve renal insufficiency caused by podocyte dysfunction and prevents renal parenchymal damage.